- 21 September
-
On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.
- 18 September
-
The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.
- 14 September
-
On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.
- 04 September
-
More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.
- Home
- Cluster members
- NIKA LLC
NIKA LLC
LLC “NIKA” manufactures disposable ECG electrodes for the collection and transmission of bioelectrical cardiac signals from the surface of the patient’s skin to devices that record and/or process these signals (electrocardiographs, vectocardiographs, electrocardiographic monitors, patient monitoring systems).
NIKA LLC has been serving the Russian healthcare industry for over 16 years. Starting as n equipment supplier, the company is now a modern, full-cycle manufacturing facility and a leader in the functional diagnostic consumables market.
Own product line.
In 2017, we took a decisive step: we launched disposable ECG electrodes under our own brand, NIKA-MEDICAL. This isn’t just import substitution. It is a product created with an understanding of the real-world working conditions of physicians and the specifics of the Russian healthcare system.
Proven quality.
We don’t skimp on raw materials. We use only high-quality materials from trusted, long-established suppliers. This is why NIKA-MEDICAL electrodes provide stable resistance, a clear baseline, and artifact resistance, even during long-term monitoring.
A Geography of Trust.
Today, NIKA-MEDICAL electrodes are used throughout the country, from Kaliningrad to Yuzhno-Sakhalinsk. But the company’s greatest pride is the trust of the professional community.
Leaders choose us.
NIKA-MEDICAL electrodes are used by leading Russian medical equipment manufacturers:
NIMP ESN LLC (MIOKARD trademark);
AKSION Concern LLC;
NMF NEUROTECH LLC (wireless solutions and electrophysiology).
Cooperation with such partners is more than just a sign of quality. It is recog nition of the technological advancement of our products, which meets industry standards.
NIKA LLC – we make diagnostics more precise.
NIKA LLC
Office: 620043, Yekaterinburg,
Repina Street, 42a, office 406
